Literature DB >> 7622914

Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone.

R Malinverni1, C C Kuo, L A Campbell, J T Grayston.   

Abstract

To study persistent infection, reactivation of Chlamydia pneumoniae lung infection in mice was attempted by immunosuppression with cortisone treatment. Four-week-old Swiss-Webster mice were treated with cortisone acetate (125 mg/kg) every other day for a total of six doses, starting on day 28 after intranasal inoculation of C. pneumoniae AR-39. C. pneumoniae was recovered from the lungs in 6 of 13 animals after six doses of cortisone, while control animals given saline remained negative. C. pneumoniae DNA was detected by polymerase chain reaction in the 6 culture-positive mice and 2 of 10 controls. The presence of pathogen DNA in this animal model suggested viable organisms in a culture-negative state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622914     DOI: 10.1093/infdis/172.2.593

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Authors:  Shusaku Haranaga; Hideaki Ikejima; Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

4.  Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.

Authors:  N Tsumura; U Emre; P Roblin; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

5.  Reactivation of chlamydial genital tract infection in mice.

Authors:  T W Cotter; G S Miranpuri; K H Ramsey; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

Review 8.  Chlamydia pneumoniae and cardiovascular disease.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

9.  Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.

Authors:  Seoung-Ju Park; Yong-Chul Lee; Yang-Keun Rhee; Heung-Bum Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

10.  Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Authors:  J M Penttilä; M Anttila; M Puolakkainen; A Laurila; K Varkila; M Sarvas; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.